Yinhua CSI Chinese Medicine ETF (562390)
- Open
- 0.888
- High
- 0.911
- Low
- 0.888
- Prev. Close
- 0.886
- Volume
- 27.75K
- Turnover
- 2.51M
- Avg Price
- 0.905
- Bid/Ask Ratio
- -10.79%
- Amplitude
- 2.60%
- 52wk High
- 1.062
- Volume Ratio
- 0.20
- Turnover Ratio
- 0.00%
News
- PUBT · 8 hours ago
Dong-E-E-Jiao, China Resources Pharma subsidiary, posts H1 net profit RMB 860.38 million, up 5.66%
- PUBT · Aug 14 at 06:28 AM
YNBY International H1 FY26 profit attributable to owners rises 13.31% to HK$ 2.69 million; revenue more than doubled to HK$ 762.54 million
- PUBT · Aug 14 at 03:45 AM
Tong Ren Tang Technologies schedules board meeting on interim results, dividend decision
- 同壁财经 · Jun 8 at 06:10 AM
China and the U.S. dual clinical approval, Yunnan Baiyao's first biological innovative drug welcomes a new milestone
- 同壁财经 · May 30 at 10:02 AM
DEEJ has continuously received a Wind ESG A rating, with a comprehensive score of 7.73
- 同壁财经 · May 28 at 08:37 PM
CR Sanjiu will distribute over 1.7 billion in cash in 2025, highlighting a high dividend payout that underscores its dividend characteristics
